American Journal of Respiratory and Critical Care Medicine | 2019
Sex Hormones and Asthma: Don’t Forget Progesterone
Abstract
(2). Although both these therapies can have significant benefits to patients, they also have significant complications and costs associated with them that far exceed those that have been reported in patients undergoing endobronchial lung volume reduction therapy (2, 3). We also wholeheartedly agree with Dr. Jain that future research should focus on better predictors of patient outcomes, the minimization of risk, and providing improved outcomes in the most cost-effective fashion. n